Jump to page content
An event by Kenes Group Delve into the challenges in Precision Medicine with the inaugural Summit on Controversies in Precision Medicine, which will take place in Berlin, 13-15 November 2017. - Why are the results from genetics-driven precision medicine and systems biology too slow?
- Are we getting lost in Big Data?
- Should there be a stronger role of physiological models and phenotypic data in drug R&D?
- How can companies manage their processes and strategies to develop a more agile approach? The summit, under the leadership of Professor Dan Peer (Director, Tel Aviv University Cancer Biology Research Center), will explore these questions and more, to facilitate discussions on future ways to increase the productivity of biopharmaceutical and clinical innovation.
Be part of 100+ senior level attendees from leading industry companies, academia and government institutions who are putting innovation in their pipeline.

To learn more, click here.